Doximity, Inc. (DOCS) Form 8-K — Aug 6, 2026

$DOCSForm 8-KItems 2.02, 9.01Filed Aug 6, 2026, 4:04 PM ET0001516513-26-000038Original filing

Doximity (NYSE: DOCS) reported fiscal 2027 first quarter results for the quarter ended June 30, 2026, with total revenue of $156.6 million, up 7% year-over-year, a growth rate management described as accelerated. Profitability moved sharply lower: GAAP net income fell to $24.3 million (15.5% margin) from $53.3 million (36.5%) a year earlier, adjusted EBITDA declined 6% to $74.8 million, and free cash flow dropped 34% to $39.6 million as stock-based compensation rose to $36.8 million from $21.9 million.

Key figures

Eps: 0.13
Revenue: $156.6 million
Guidance: Fiscal Q2 (ending Sept 30, 2026): revenue $170-171 million, adjusted EBITDA $80.5-81.5 million; fiscal year ending March 31, 2027: revenue $671-681 million, adjusted EBITDA $309-329 million
Net Income: $24.3 million
Revenue Yoy: +7%
Total Assets: $1.08 billion
Cash Position: $273.6 million
Free Cash Flow: $39.6 million (down 34% YoY)
Adjusted Ebitda: $74.8 million (down 6% YoY, 47.7% margin vs 54.7%)
Non Gaap Net Income: $55.0 million (35.1% margin, vs $71.9 million / 49.2% prior year)
Non Gaap Diluted Eps: 0.29
Operating Cash Flow: $42.0 million (down 32% YoY)
Q1 Share Repurchases: $91.6 million
Ai Search Query Growth: over 25% quarter-over-quarter
Marketable Securities: $414.2 million
Stock Based Compensation: $36.8 million (vs $21.9 million prior year)
Workflow Active Prescriber Growth: more than 30% year-over-year

Price after filing

1 day: -1.2%7 days: +21.5%30 days: +20.4%

Close on the filing date to close N calendar days later (from $21.89). Historical, not a forecast.

AI analysis

Red flags5 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.